Holen Sie sich die Stockscreener-App
206.23
0.77%
-1.605
Schlusskurs vom Vortag:
$207.84
Offen:
$208.83
24-Stunden-Volumen:
790.44K
Relative Volume:
0.62
Marktkapitalisierung:
$28.76B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$-309.19M
KGV:
-90.29
EPS:
-2.2841
Netto-Cashflow:
$93.57M
1W Leistung:
+1.57%
1M Leistung:
-13.31%
6M Leistung:
+30.77%
1J Leistung:
+20.79%
1-Tages-Spanne:
$204.04
$213.30
1-Wochen-Bereich:
$203.86
$214.36
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
206.23 | 28.98B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Prenatal Testing Co. Missed Fatal Condition, Couple Say - Law360
Krilogy Financial LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Allspring Growth Fund Q4 2025 Fund Performers And Detractors - Seeking Alpha
Envestnet Asset Management Inc. Purchases 17,254 Shares of Natera, Inc. $NTRA - MarketBeat
How Natera Inc. stock trades before earnings2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? - 富途牛牛
Natera Inc (NTRA) Trading 3.93% Higher on Feb 9 - GuruFocus
Natera's Signatera test to be covered under Medicare - MSN
Earnings Miss: What are analysts price targets for Natera Inc2025 Market Overview & Pattern Based Trade Signal System - baoquankhu1.vn
Natera, Inc. $NTRA Shares Sold by Savant Capital LLC - MarketBeat
Is Natera (NTRA) Quietly Redefining Its Moat With Multi-Front Cell-Free DNA Expansion? - simplywall.st
IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes - Yahoo Finance
AGF Management Ltd. Sells 6,300 Shares of Natera, Inc. $NTRA - MarketBeat
This brand-new Peninsula building sat vacant for a year. Now it's landed two big tenants - The Business Journals
News | Genetic testing firm inks deal at Silicon Valley life science campus - CoStar
C WorldWide Group Holding A S Decreases Stock Position in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Purchased by Thrivent Financial for Lutherans - MarketBeat
Natera CEO sells $20.7 million in NTRA stock By Investing.com - Investing.com South Africa
Natera sec. and chief legal officer sells $307k in stock By Investing.com - Investing.com Nigeria
Natera sec. and chief legal officer sells $307k in stock - Investing.com UK
Natera director Sheena Jonathan sells $100k in stock By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 4,725 Shares - MarketBeat
Natera (NASDAQ:NTRA) Insider Sells $378,232.03 in Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera files Signatera CDx PMA with FDA for bladder cancer MRD test - MSN
Natera CFO Brophy sells $1.58 million in NTRA stock By Investing.com - Investing.com Canada
Natera Inc: President Moshkevich sells $1.07 million in NTRA stock By Investing.com - Investing.com Nigeria
Natera (NASDAQ:NTRA) Insider Sells $830,285.88 in Stock - MarketBeat
Natera Inc. president Fesko sells $830k in stock By Investing.com - Investing.com Nigeria
Natera CEO sells $20.7 million in NTRA stock - Investing.com
Natera Inc: President Moshkevich sells $1.07 million in NTRA stock - Investing.com
Oversold Conditions For Natera (NTRA) - Nasdaq
Natera Inc (NTRA) Stock Price Down 7.82% on Feb 4 - GuruFocus
Principal Financial Group Inc. Has $69.11 Million Stake in Natera, Inc. $NTRA - MarketBeat
National Pension Service Invests $1.49 Million in Natera, Inc. $NTRA - MarketBeat
Trading Systems Reacting to (NTRA) Volatility - Stock Traders Daily
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test - The Globe and Mail
Exploring US High Growth Tech Stocks This February 2026 - simplywall.st
Natera submits FDA approval for bladder cancer test By Investing.com - Investing.com Nigeria
Natera Files FDA PMA for Signatera CDx in Muscle-Invasive Bladder Cancer - Oncodaily
Natera, Inc. (NTRA) Stock Analysis: Potential Growth Amidst Strong Analyst Confidence - DirectorsTalk Interviews
FDA premarket approval sought for Signatera CDx test in MIBC - Urology Times
Natera Submits Signatera™ CDx PMA to FDA - MEXC
Natera Submits Premarket Approval Application for Molecular Residual Disease Test Signatera CDx - marketscreener.com
NTRA Submits PMA to FDA for Bladder Cancer Detection Innovation - GuruFocus
Natera submits Signatera(TM) CDx PMA to FDA - marketscreener.com
Natera submits FDA approval for bladder cancer test - Investing.com
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):